The company said, “The Company is increasing full-year 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million and projected full-year 2025 Modern Oral sales to $125.0 – 130.0 million.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPB: